Stock listing
Pharmala Biotech Holdings, Inc.
Selected listing: MDMA · CSE · CAD · CA
Pharmala Biotech Holdings, Inc. (CSE:MDMA), Health Technology. Latest release Sep 18, 2026: PharmAla Biotech Provides Corporate Update, Change of Auditor…
- Ticker
- CSE:MDMA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- CSE
- Currency
- CAD
About Pharmala Biotech Holdings, Inc.
Pharmala Biotech Holdings, Inc. is a public company listed under the ticker MDMA on the Canadian market. Pharmala focuses on the development of psychedelic compounds for therapeutic use, aiming to advance the understanding and application of these substances in the healthcare sector.
Latest news from Pharmala Biotech Holdings, Inc.
PharmAla Biotech Provides Corporate Update, Change of Auditor, Retention of Watertower Research and Oak Hill
September 18, 2026
PharmAla Biotech Provides Corporate Update: Change of Auditor, Retention of Watertower Research and Oak Hill
September 17, 2026
PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner
August 21, 2026
PharmAla Issues Q3 Financial Statements and AGM Update
July 30, 2026
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
July 21, 2026
Research Pharmala Biotech Holdings, Inc.
Pharmala Biotech Holdings, Inc. company profile
View the public company page for Pharmala Biotech Holdings, Inc. on 6ix.
Pharmala Biotech Holdings, Inc. news
Read company news and market updates connected to Pharmala Biotech Holdings, Inc..
Pharmala Biotech Holdings, Inc. investor events
Find investor webinars, events, and replay context for Pharmala Biotech Holdings, Inc..